table of content
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence Drug R&D Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence Drug R&D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug R&D Overall Market Size
2.1 Global Artificial Intelligence Drug R&D Market Size: 2022 VS 2029
2.2 Global Artificial Intelligence Drug R&D Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence Drug R&D Players in Global Market
3.2 Top Global Artificial Intelligence Drug R&D Companies Ranked by Revenue
3.3 Global Artificial Intelligence Drug R&D Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence Drug R&D Companies in Global Market, by Revenue in 2022
3.5 Global Companies Artificial Intelligence Drug R&D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence Drug R&D Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence Drug R&D Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug R&D Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Artificial Intelligence Drug R&D Market Size Markets, 2022 & 2029
4.1.2 AI Platfrom
4.1.3 Analytics Service
4.2 By Type - Global Artificial Intelligence Drug R&D Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence Drug R&D Revenue, 2018-2023
4.2.2 By Type - Global Artificial Intelligence Drug R&D Revenue, 2024-2029
4.2.3 By Type - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence Drug R&D Market Size, 2022 & 2029
5.1.2 Drug Discovery
5.1.3 Precision Medicine
5.2 By Application - Global Artificial Intelligence Drug R&D Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence Drug R&D Revenue, 2018-2023
5.2.2 By Application - Global Artificial Intelligence Drug R&D Revenue, 2024-2029
5.2.3 By Application - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Artificial Intelligence Drug R&D Market Size, 2022 & 2029
6.2 By Region - Global Artificial Intelligence Drug R&D Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence Drug R&D Revenue, 2018-2023
6.2.2 By Region - Global Artificial Intelligence Drug R&D Revenue, 2024-2029
6.2.3 By Region - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Artificial Intelligence Drug R&D Revenue, 2018-2029
6.3.2 US Artificial Intelligence Drug R&D Market Size, 2018-2029
6.3.3 Canada Artificial Intelligence Drug R&D Market Size, 2018-2029
6.3.4 Mexico Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence Drug R&D Revenue, 2018-2029
6.4.2 Germany Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.3 France Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.4 U.K. Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.5 Italy Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.6 Russia Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.7 Nordic Countries Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.8 Benelux Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence Drug R&D Revenue, 2018-2029
6.5.2 China Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.3 Japan Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.4 South Korea Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.5 Southeast Asia Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.6 India Artificial Intelligence Drug R&D Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Artificial Intelligence Drug R&D Revenue, 2018-2029
6.6.2 Brazil Artificial Intelligence Drug R&D Market Size, 2018-2029
6.6.3 Argentina Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, 2018-2029
6.7.2 Turkey Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7.3 Israel Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7.4 Saudi Arabia Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7.5 UAE Artificial Intelligence Drug R&D Market Size, 2018-2029
7 Artificial Intelligence Drug R&D Companies Profiles
7.1 IBM Watson
7.1.1 IBM Watson Company Summary
7.1.2 IBM Watson Business Overview
7.1.3 IBM Watson Artificial Intelligence Drug R&D Major Product Offerings
7.1.4 IBM Watson Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.1.5 IBM Watson Key News & Latest Developments
7.2 BioXel
7.2.1 BioXel Company Summary
7.2.2 BioXel Business Overview
7.2.3 BioXel Artificial Intelligence Drug R&D Major Product Offerings
7.2.4 BioXel Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.2.5 BioXel Key News & Latest Developments
7.3 Insilico Medicine
7.3.1 Insilico Medicine Company Summary
7.3.2 Insilico Medicine Business Overview
7.3.3 Insilico Medicine Artificial Intelligence Drug R&D Major Product Offerings
7.3.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.3.5 Insilico Medicine Key News & Latest Developments
7.4 Gatehouse Bio
7.4.1 Gatehouse Bio Company Summary
7.4.2 Gatehouse Bio Business Overview
7.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Major Product Offerings
7.4.4 Gatehouse Bio Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.4.5 Gatehouse Bio Key News & Latest Developments
7.5 Google DeepMind
7.5.1 Google DeepMind Company Summary
7.5.2 Google DeepMind Business Overview
7.5.3 Google DeepMind Artificial Intelligence Drug R&D Major Product Offerings
7.5.4 Google DeepMind Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.5.5 Google DeepMind Key News & Latest Developments
7.6 Genpact Cora
7.6.1 Genpact Cora Company Summary
7.6.2 Genpact Cora Business Overview
7.6.3 Genpact Cora Artificial Intelligence Drug R&D Major Product Offerings
7.6.4 Genpact Cora Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.6.5 Genpact Cora Key News & Latest Developments
7.7 Cyclica Inc
7.7.1 Cyclica Inc Company Summary
7.7.2 Cyclica Inc Business Overview
7.7.3 Cyclica Inc Artificial Intelligence Drug R&D Major Product Offerings
7.7.4 Cyclica Inc Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.7.5 Cyclica Inc Key News & Latest Developments
7.8 QuantumBlack
7.8.1 QuantumBlack Company Summary
7.8.2 QuantumBlack Business Overview
7.8.3 QuantumBlack Artificial Intelligence Drug R&D Major Product Offerings
7.8.4 QuantumBlack Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.8.5 QuantumBlack Key News & Latest Developments
7.9 Nq Medical
7.9.1 Nq Medical Company Summary
7.9.2 Nq Medical Business Overview
7.9.3 Nq Medical Artificial Intelligence Drug R&D Major Product Offerings
7.9.4 Nq Medical Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.9.5 Nq Medical Key News & Latest Developments
7.10 Phenomic AI
7.10.1 Phenomic AI Company Summary
7.10.2 Phenomic AI Business Overview
7.10.3 Phenomic AI Artificial Intelligence Drug R&D Major Product Offerings
7.10.4 Phenomic AI Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.10.5 Phenomic AI Key News & Latest Developments
7.11 Palantir Technologies
7.11.1 Palantir Technologies Company Summary
7.11.2 Palantir Technologies Business Overview
7.11.3 Palantir Technologies Artificial Intelligence Drug R&D Major Product Offerings
7.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.11.5 Palantir Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
